发明名称 Therapeutic methods and compositions involving isoflavones
摘要 The use, in the manufacture of medicaments that contain dehydroequal of the formula depicted, are described. Application of compositions containing the dehydroequol have particular utility and effectiveness in the treatment, prophylaxis, amelioration defence against, and/or prevention of menopausal syndrome including hot flushes, anxiety, and depression, mood swings, night sweats, headaches, and urinary incontinence; osteoporosis; fluid retention, cyclical mastalgia, and dysmenorrhoea; Reynaud's Syndrome; Reynaud's Phenomenon; Buergers Disease; coronary artery spasm; migraine headaches; hypertension; benign prostatic hypertrophy; breast cancer; uterine cancer; ovarian cancer; testicular cancer; large bowel cancer; endometrial cancer; prostatic cancer; uterine cancer; atherosclerosis; Alzheimer's Disease; inflammatory diseases including inflammatory bowel disease, ulcerative colitis, Crohn's Disease; rheumatic diseases including rheumatoid arthritis; acne; baldness including male pattern baldness (alopecia hereditaria); psoriasis and diseases associated with oxidant stress including cancer, myocardial infarction, stroke, arthritis, sunlight induced skin damage or cataracts. (62) Divided out of 334025
申请公布号 NZ506063(A) 申请公布日期 2004.12.24
申请号 NZ19970506063 申请日期 1997.08.29
申请人 NOVOGEN RESEARCH PTY LIMITED 发明人 JOANNOU, GEORGE EUSTACE;KELLY, GRAHAM EDMUND
分类号 A23L2/52;A23L1/30;A61K8/49;A61K31/12;A61K31/122;A61K31/352;A61K31/353;A61K31/355;A61K31/382;A61K31/40;A61K31/404;A61K31/47;A61K31/4745;A61P1/04;A61P5/30;A61P9/10;A61P9/12;A61P13/08;A61P17/02;A61P17/12;A61P17/14;A61P19/02;A61P19/10;A61P25/00;A61P27/12;A61P29/00;A61P35/00;A61P39/06;A61Q7/00;A61Q19/00;C07C45/46;C07C45/67;C09K15/08;C09K15/30;C12P7/26;C12P17/04;C12P17/10;(IPC1-7):A61K31/35;A61K31/351 主分类号 A23L2/52
代理机构 代理人
主权项
地址